These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Are integrin alpha(2)beta(1), glycoprotein Ib and vWf levels correlated with their contributions to platelet adhesion on collagen under high-shear flow? Jung SM; Sonoda M; Tsuji K; Jimi A; Nomura S; Kanaji T; Moroi M Platelets; 2010; 21(2):101-11. PubMed ID: 20063990 [TBL] [Abstract][Full Text] [Related]
24. Regulation of von Willebrand factor binding to the platelet glycoprotein Ib-IX by a membrane skeleton-dependent inside-out signal. Englund GD; Bodnar RJ; Li Z; Ruggeri ZM; Du X J Biol Chem; 2001 May; 276(20):16952-9. PubMed ID: 11278380 [TBL] [Abstract][Full Text] [Related]
25. The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation. Delaney MK; Liu J; Zheng Y; Berndt MC; Du X Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2761-8. PubMed ID: 22995516 [TBL] [Abstract][Full Text] [Related]
26. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999 [TBL] [Abstract][Full Text] [Related]
27. Signaling through GP Ib-IX-V activates alpha IIb beta 3 independently of other receptors. Kasirer-Friede A; Cozzi MR; Mazzucato M; De Marco L; Ruggeri ZM; Shattil SJ Blood; 2004 May; 103(9):3403-11. PubMed ID: 14726383 [TBL] [Abstract][Full Text] [Related]
29. Regulation of glycoprotein Ib-IX-von Willebrand factor interaction by cAMP-dependent protein kinase-mediated phosphorylation at Ser 166 of glycoprotein Ib(beta). Bodnar RJ; Xi X; Li Z; Berndt MC; Du X J Biol Chem; 2002 Dec; 277(49):47080-7. PubMed ID: 12361948 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of adhesive and signaling functions of the platelet GPIb-V-IX complex by a cell penetrating GPIbalpha peptide. David T; Ohlmann P; Eckly A; Moog S; Cazenave JP; Gachet C; Lanza F J Thromb Haemost; 2006 Dec; 4(12):2645-55. PubMed ID: 17100656 [TBL] [Abstract][Full Text] [Related]
31. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa. Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012 [TBL] [Abstract][Full Text] [Related]
32. Role of 14-3-3ζ in platelet glycoprotein Ibα-von Willebrand factor interaction-induced signaling. Zhang W; Zhao L; Liu J; Du J; Yan R; Dai K Int J Mol Sci; 2012; 13(5):5364-5374. PubMed ID: 22754302 [TBL] [Abstract][Full Text] [Related]
33. Activation of pp125FAK by type 2B recombinant von Willebrand factor binding to platelet GPIb at a high shear rate occurs independently of alpha IIb beta 3 engagement. Mekrache M; Bachelot-Loza C; Ajzenberg N; Saci A; Legendre P; Baruch D Blood; 2003 Jun; 101(11):4363-71. PubMed ID: 12543870 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease. Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369 [TBL] [Abstract][Full Text] [Related]
35. Phenotype changes resulting in high-affinity binding of von Willebrand factor to recombinant glycoprotein Ib-IX: analysis of the platelet-type von Willebrand disease mutations. Tait AS; Cranmer SL; Jackson SP; Dawes IW; Chong BH Blood; 2001 Sep; 98(6):1812-8. PubMed ID: 11535515 [TBL] [Abstract][Full Text] [Related]
36. von Willebrand factor stimulates thrombin-induced exposure of procoagulant phospholipids on the surface of fibrin-adherent platelets. Briedé JJ; Wielders SJ; Heemskerk JW; Baruch D; Hemker HC; Lindhout T J Thromb Haemost; 2003 Mar; 1(3):559-65. PubMed ID: 12871466 [TBL] [Abstract][Full Text] [Related]
37. GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events. Gardiner EE; Arthur JF; Shen Y; Karunakaran D; Moore LA; Am Esch JS; Andrews RK; Berndt MC Platelets; 2010; 21(4):244-52. PubMed ID: 20367574 [TBL] [Abstract][Full Text] [Related]
38. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease. Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351 [TBL] [Abstract][Full Text] [Related]
39. The von Willebrand factor-glycoprotein Ib/V/IX interaction induces actin polymerization and cytoskeletal reorganization in rolling platelets and glycoprotein Ib/V/IX-transfected cells. Yuan Y; Kulkarni S; Ulsemer P; Cranmer SL; Yap CL; Nesbitt WS; Harper I; Mistry N; Dopheide SM; Hughan SC; Williamson D; de la Salle C; Salem HH; Lanza F; Jackson SP J Biol Chem; 1999 Dec; 274(51):36241-51. PubMed ID: 10593912 [TBL] [Abstract][Full Text] [Related]
40. Polyphosphate binds to human von Willebrand factor in vivo and modulates its interaction with glycoprotein Ib. Montilla M; Hernández-Ruiz L; García-Cozar FJ; Alvarez-Laderas I; Rodríguez-Martorell J; Ruiz FA J Thromb Haemost; 2012 Nov; 10(11):2315-23. PubMed ID: 23006049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]